Description
Catalogue Number | IM036245 |
CAS No. | 28860-95-9 |
Alternate CAS No. | Monohydrate: 38821-49-7 |
Chemical Name | (S)-(-)-Carbidopa |
Synonyms | (αS)-α-Hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic Acid; (-)-L-α-Hydrazino-3,4-dihydroxy-α-methylhydrocinamic Acid; (S)-Carbidopa; 1-α-(3,4-Dihydroxybenzyl)-α-hydrazinopropionic Acid; Carbidopa; HMD; Hydrazino-α-methyldopa; L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic Acid; L-α-(3,4-Dihydroxybenzyl)-α-hydrazinopropionic Acid; L-α-Methyl-β-(3,4-dihydroxyphenyl)-α-hydrazinopropionic Acid; L-α-Methyldopahydrazine; Lodosin; Lodosyn; MK 486; N-Aminomethyldopa; α-Hydrazino-α-methyl-β-(3,4-dihydroxyphenyl)propionic Acid; α-Methyldopahydrazine; |
Molecular Formula | C₁₀H₁₄N₂O₄ |
Molecular Weight | 226.23 |
Appearance | White to Off-White Solid |
Melting Point | >181°C (dec.) |
Storage | 4°C, Hygroscopic |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Stability | Hygroscopic, Unstable in Solution |
Applications | (S)-(-)-Carbidopa is a peripheral decarboxylase inhibitor that is commonly used in combination with L-DOPA (D533751) for treatment of Parkinsonism. S(-)-Carbidopa ( has also been shown to prolong the elimination half-life of L-DOPA from blood plasma and skeletal muscle. |
Category | Standards; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites; |
Note: All Products are stable to be shipped at room temperature, unless otherwise specified.
Reviews
There are no reviews yet.